United Therapeutics (UTHR) Receivables (2009 - 2026)
United Therapeutics (UTHR) posted Receivables of $312.0 million for Q1 2026, down 10.91% sequentially from $350.2 million in Q4 2025, and down 3.11% YoY from $322.0 million in Q1 2025.
United Therapeutics (UTHR) Receivables (2009 - 2026) Analysis & Trends
United Therapeutics has reported Receivables for 18 years, with the latest figure at $312.0 million in Q1 2026.
- Quarterly Receivables fell 3.11% year-over-year to $312.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $312.0 million (down 3.11% YoY) and the FY2025 annual result came in at $350.2 million, up 25.38% from the prior year.
- Receivables eased to $312.0 million in Q1 2026 per UTHR's latest filing, from $350.2 million in the prior quarter.
- Over five years, Receivables peaked at $379.3 million in Q2 2025 and troughed at $134.5 million in Q1 2023.
- A 5-year average of $271.8 million and a median of $279.3 million in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2023 and 2024: Receivables decreased 21.11% in 2023, then surged 128.48% in 2024.
- Over 5 years, Receivables stood at $220.4 million in 2022, then climbed by 26.54% to $278.9 million in 2023, then grew by 0.14% to $279.3 million in 2024, then advanced by 25.38% to $350.2 million in 2025, then slipped by 10.91% to $312.0 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $312.0 million, $350.2 million, and $297.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.08 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 456.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 310.30 Mn |
| Mar 31, 2026 | 312.00 Mn |
| Dec 31, 2025 | 350.20 Mn |
| Sep 30, 2025 | 297.70 Mn |
| Jun 30, 2025 | 379.30 Mn |
| Mar 31, 2025 | 322.00 Mn |
| Dec 31, 2024 | 279.30 Mn |
| Sep 30, 2024 | 341.80 Mn |
| Jun 30, 2024 | 290.70 Mn |
| Mar 31, 2024 | 307.30 Mn |
| Dec 31, 2023 | 278.90 Mn |
| Sep 30, 2023 | 258.60 Mn |
| Jun 30, 2023 | 272.70 Mn |
| Mar 31, 2023 | 134.50 Mn |
| Dec 31, 2022 | 220.40 Mn |
| Sep 30, 2022 | 231.70 Mn |
| Jun 30, 2022 | 173.40 Mn |
| Mar 31, 2022 | 170.50 Mn |
| Dec 31, 2021 | 198.70 Mn |
| Sep 30, 2021 | 212.80 Mn |